Who
Scott M. Pittman
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Cytomedix Inc Com New.
In numbers
- Trades disclosed
- 79
- Buys
- 2
- Sells
- 0
- Bought
- $1.4M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 May 2016
- Last trade
- 6 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 6 Oct 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | $6,7504,500 at $1.50 | filing |
| 6 Oct 2026filed 6 Oct 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | $687458 at $1.50 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code M | $40K40,000 at $1.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code F | $40K39,604 at $1.01 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code M | —40,000 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code M | —40,000 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeutics | SEC FORM 4 Code M | $40K40,000 at $1.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeutics | SEC FORM 4 Code F | $40K39,604 at $1.01 | filing |
| 29 Jun 2026filed 2 Jul 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | $26K17,450 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code D | $55K36,750 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code D | $11K7,516 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code A | $26K17,450 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code D | $55K36,750 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code D | $11K7,516 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code A | $26K17,500 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code A | $11K7,333 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | $26K17,500 at $1.50 | filing |
| 29 May 2026filed 2 Jun 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | $11K7,333 at $1.50 | filing |
News
No headline names them, or the companies they trade most, lately.